Vanguard Portfolio Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
Vanguard Portfolio Management's PBYI Position: Q3 2026 in Review
Vanguard Portfolio Management increased its Puma Biotechnology (PBYI) stake by 3.7% in Q3 2026, buying an estimated $596K and bringing the position to 1,893,279 shares worth $18.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.
Vanguard Portfolio Management first reported a position in PBYI in Q1 2026 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Vanguard Portfolio Management held 1,893,279 shares of Puma Biotechnology worth $18.8M as of Q3 2026.
- Vanguard Portfolio Management bought 67,680 Puma Biotechnology shares in Q3 2026, an estimated $596K.
- Puma Biotechnology made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1971 holding.
- Vanguard Portfolio Management first reported a position in Puma Biotechnology in Q1 2026 and has held it in 3 quarters since.
- 123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.